EP3303394
Mótefni gegn CTLA-4 og aðferðir til notkunar þeirra
:
EP Einkaleyfi fallið úr gildi:
27.5.2016:
8.4.2020:
16728509.7
:
26.6.2020:
15.7.2020
:
26.5.2036
:
ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
27.5.2016
8.4.2020
26.6.2020
15.7.2020
:
Agenus Inc.:
3 Forbes Road, Lexington, MA 02421, US
:
Ludwig Institute for Cancer Research Ltd:
Stadelhoferstrasse 22, 8001 Zürich, CH
:
Memorial Sloan Kettering Cancer Center:
1275 York Avenue, New York, NY 10065, US
:
van DIJK, Marc:
3722ZH Bilthoven, NL
:
MUNDT, Cornelia, Anne:
79539 Loerrach, DE
:
RITTER, Gerd:
New York, NY 10017, US
:
SCHAER, David:
Mamaroneck, NY 10543, US
:
WOLCHOK, Jedd, David:
New York, NY 10016, US
:
MERGHOUB, Taha:
Jersey City, NJ 07306, US
:
SAVITSKY, David, Adam:
Boxford, MA 01921, US
:
FINDEIS, Mark, Arthur:
Belmont, MA 02478, US
:
WILSON, Nicholas, Stuart:
Somerville, MA 02144, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201562168391 P:
29.5.2015:
US
:
201562182363 P:
19.6.2015:
US
:
201562190653 P:
9.7.2015:
US
:
201562257202 P:
18.11.2015:
US
:
201662280263 P:
19.1.2016:
US
:
201662292500 P:
8.2.2016:
US
:
201662294558 P:
12.2.2016:
US
:
201662323226 P:
15.4.2016:
US
:
US2016034508:
27.5.2016
:
C07K 16/28